None.
None.
No insider has filed a notice of proposed sale (Form 144) for DNA X Inc in the last 12 months.
No 13F manager reports holding SONM.
| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
VT
Vanguard Index Funds
|
$95.3K | 44.5K | 2.99% | 0.00% | March 31, 2025 |
|
VE
Vanguard Index Funds
|
$53.2K | 88.1K | 5.92% | 0.00% | September 30, 2025 |
9 more funds behind a free account
See every fund holding DNA X Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
ON
Orbic North America, LLC.
5%+ holder
13D · 33.1%
|
1.9M | 130.85% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
AN
Ashima Narula
5%+ holder
13D · 33.1%
|
1.9M | 130.85% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
Loading...